Identification of Serum CMTM2 as a Potential Biomarker for HBV-Related Disorders

Identification of Serum CMTM2 as a Potential Biomarker for HBV-Related Disorders:

Substantial advance supports that CMTM2 serve as an important performer in physiological and pathological processes. However, very little is clear about the relationship between CMTM2 and HBV-related disorders. Here, for the first time, we explore that whether or not serum CMTM2 is involved in HBV-related diseases. We found that CMTM2 values were significantly lower in patients compared to healthy control (p